Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Total Current Liabilities: 2010-2025

Historic Total Current Liabilities for Exponent (EXPO) over the last 13 years, with Jan 2025 value amounting to $163.2 million.

  • Exponent's Total Current Liabilities rose 12.36% to $154.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was $154.8 million, marking a year-over-year increase of 12.36%. This contributed to the annual value of $163.2 million for FY2025, which is 0.79% up from last year.
  • As of FY2025, Exponent's Total Current Liabilities stood at $163.2 million, which was up 0.79% from $161.9 million recorded in FY2023.
  • Over the past 5 years, Exponent's Total Current Liabilities peaked at $163.2 million during FY2025, and registered a low of $117.3 million during FY2021.
  • Moreover, its 2-year median value for Total Current Liabilities was $162.5 million (2023), whereas its average is $162.5 million.
  • The largest annual percentage gain for Exponent's Total Current Liabilities in the last 5 years was 30.41% (2021), contrasted with its biggest fall of 5.37% (2021).
  • Exponent's Total Current Liabilities (Yearly) stood at $117.3 million in 2021, then soared by 30.41% to $153.0 million in 2021, then climbed by 3.95% to $159.0 million in 2022, then grew by 1.81% to $161.9 million in 2023, then climbed by 0.79% to $163.2 million in 2025.